MarcAndrewRiedlMD

PubMed

• A core outcome set for efficacy of acute treatment of hereditary angioedema.
  Remy S Petersen, Lauré M Fijen, Christian Apfelbacher, Markus Magerl, Karsten Weller, Werner Aberer, Adil Adatia, Paul Audhya, Noémi-Anna Bara, Stephen Betschel, Isabe...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2024 Apr 10
• Clinical Progress in Hepatic Targeting for Novel Prophylactic Therapies in Hereditary Angioedema.
  Marc A Riedl, Laura Bordone, Alexey Revenko, Kenneth B Newman, Danny M Cohn> ;The Journal of Allergy and Clinical Immunology. in Practice. 2024 Apr 1
• Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysis.
  Li, H., Bajcic, P., Rodino, F., Wang, S., Sexton, T., Lumry, W., Craig, T., Anderson, J., Riedl, M., Tachdjian, R., Manning, M., Bernstein, J.> ;Allergy, Asthma, and Clinical Immunology. 2023 Dec 11
• Hereditary angioedema outcomes in US patients switched from injectable long-term prophylactic medication to oral berotralstat.
  Marc A Riedl, Daniel Soteres, J Wesley Sublett, Bhavisha Desai, Dianne Tomita, Phil Collis, , Jonathan A Bernstein> ;Annals of Allergy, Asthma & Immunology. 2024 Apr 1
• Refractory Status Epilepticus Associated With a Pathogenic Variant in TNFRSF13B.
  Yang, J., Scanlon, N., Woo, W., LaBuzetta, J., Gonzalez, C., Broderick, L., Doherty, T., Riedl, M., Dunn-Pirio, A.> ;Cureus. 2023 Nov 1
• Hereditary angioedema in older adults: Understanding the patient perspective.
  Alan P Baptist, George E Freigeh, Belinda Nelson, Laurie Carpenter, Nonie S Arora, Rachel P Wettenstein, Timothy Craig, Marc A Riedl> ;Annals of Allergy, Asthma & Immunology. 2024 Jan 1
• Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat.
  Danny M Cohn, Emel Aygören-Pürsün, Jonathan A Bernstein, Henriette Farkas, William R Lumry, Marcus Maurer, Andrea Zanichelli, Matthew Iverson, James Hao, Michael D Smi...> ;Clinical and Translational Allergy. 2023 Sep 1
• 2 citations
  Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate.
  Marc A Riedl, David R Hinds, Patricia M Prince, Trevor M Alvord, Sara Dosenovic, Jenna F Abdelhadi, Jack R Brownrigg, Charlotte L Camp, Thomas Machnig, Aleena Banerji> ;Allergy and Asthma Proceedings. 2023 Jul 16
• Managing Chronic Urticaria and Angioedema: Novel Insights.
  L Karla Arruda, Marc Riedl> ;The Journal of Allergy and Clinical Immunology. in Practice. 2023 Aug 1
• 1 citations
  Long-term lanadelumab treatment improves health-related quality of life in patients with hereditary angioedema.
  William R Lumry, Marcus Maurer, Karsten Weller, Marc A Riedl, Maureen Watt, Ming Yu, Giovanna Devercelli, Juliette Meunier, Aleena Banerji> ;Annals of Allergy, Asthma & Immunology. 2023 Jul 1
• 2 citations
  Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being.
  Sandra C Christiansen, Camila Lopes Veronez, Tukisa D Smith, Marc A Riedl, Bruce L Zuraw> ;Allergy and Asthma Proceedings. 2023 Mar 1
• 3 citations
  An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossov...
  Emel Aygören-Pürsün, Andrea Zanichelli, Danny M Cohn, Mauro Cancian, Roman Hakl, Tamar Kinaciyan, Markus Magerl, Inmaculada Martinez-Saguer, Marcin Stobiecki, Henriett...> ;Lancet. 2023 Feb 11
• Validation of a suspicion index to identify patients at risk for hereditary angioedema.
  Marissa Shams, Dawn A Laney, Dave A Jacob, Jingjing Yang, Jessica Dronen, Amanda Logue, Ami Rosen, Marc Riedl> ;The Journal of Allergy and Clinical Immunology. Global. 2023 Feb 1
• 1 citations
  Hereditary Angioedema During Pregnancy: Considerations in Management.
  Marc A Riedl> ;Immunology and Allergy Clinics of North America. 2023 Feb 1
• 2 citations
  Hereditary Angioedema With Normal C1 Inhibitor: US Survey of Prevalence and Provider Practice Patterns.
  Marc A Riedl, Mark Danese, Sherry Danese, Julie Ulloa, Andreas Maetzel, Paul K Audhya> ;The Journal of Allergy and Clinical Immunology. in Practice. 2023 Aug 1
• 6 citations
  Urticaria and Angioedema: Understanding Complex Pathomechanisms to Facilitate Patient Communication, Disease Management, and Future Treatment.
  George N Konstantinou, Marc A Riedl, Peter Valent, Indrashis Podder, Marcus Maurer> ;The Journal of Allergy and Clinical Immunology. in Practice. 2023 Jan 1
• 1 citations
  Differentiating histaminergic and nonhistaminergic angioedema with or without urticaria.
  Henriette Farkas, Zsuzsanna Balla, Marc A Riedl> ;The Journal of Allergy and Clinical Immunology. 2022 Dec 1
• Update on skin diseases: Urticaria, angioedema, and other skin disorders from the 2022 American College of Allergy, Asthma, and Immunology Annual Literature Review.
  Marc A Riedl> ;Annals of Allergy, Asthma & Immunology. 2023 Feb 1
• Correction: Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age.
  Florence Ida Hsu, William Lumry, Marc Riedl, Raffi Tachdjian> ;Allergy, Asthma, and Clinical Immunology. 2022 Sep 3
• 4 citations
  Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives.
  Marc A Riedl, Deborah Neville, Blaine Cloud, Bhavisha Desai, Jonathan A Bernstein> ;Allergy and Asthma Proceedings. 2022 Sep 1
• 2 citations
  Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age.
  Florence Ida Hsu, William Lumry, Marc Riedl, Raffi Tachdjian> ;Allergy, Asthma, and Clinical Immunology. 2022 Jul 13
• 1 citations
  The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update.
  Marcus Maurer, Markus Magerl, Stephen Betschel, Werner Aberer, Ignacio J Ansotegui, Emel Aygören-Pürsün, Aleena Banerji, Noémi-Anna Bara, Isabelle Boccon-Gibod, Konrad...> ;Allergy. 2022 Jul 1
• 10 citations
  Inhibition of Prekallikrein for Hereditary Angioedema.
  Lauré M Fijen, Marc A Riedl, Laura Bordone, Jonathan A Bernstein, Jason Raasch, Raffi Tachdjian, Timothy Craig, William R Lumry, Michael E Manning, Veronica J Alexande...> ;The New England Journal of Medicine. 2022 Mar 17
• 143 citations
  The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.
  Marcus Maurer, Markus Magerl, Stephen Betschel, Werner Aberer, Ignacio J Ansotegui, Emel Aygören-Pürsün, Aleena Banerji, Noémi-Anna Bara, Isabelle Boccon-Gibod, Konrad...> ;The World Allergy Organization Journal. 2022 Mar 1
• 1 citations
  Optimization of care for patients with hereditary angioedema living in rural areas
  Marc A. Riedl, Douglas T. Johnston, John Anderson, J. Allen Meadows, D. Soteres, Stephen B. LeBlanc, H. James Wedner, David M. Lang> ;Annals of Allergy, Asthma & Immunology. 2021 Oct 7
• Join now to see all

Journal Articles

• Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema Attacks  
  Jonathan A Bernstein, Lawrence B Schwartz, Andrew M Smith, H James Wedner, Daniel Soteres, Timothy Craig, Douglas T Johnston, Aleena Banerji, Paula J Busse, William R ..., JAMA
• Population Pharmacokinetics of Subcutaneous C1‐Inhibitor for Prevention of Attacks in Patients with Hereditary Angioedema  
  Jonathan A Bernstein, Marc A Riedl, Bruce Zuraw, H Henry Li, Timothy Craig, William R Lumry, Clinical and experimental allergy
• Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema  
  Marc Riedl, Jay Kashkin, Clinical Reviews in Allergy & Immunology